Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 7 | 2024 | 645 | 1.570 |
Why?
|
| Genomics | 3 | 2024 | 314 | 1.340 |
Why?
|
| Signal Transduction | 10 | 2024 | 2887 | 1.330 |
Why?
|
| Apoptosis | 6 | 2024 | 1038 | 1.150 |
Why?
|
| DNA Damage | 5 | 2024 | 280 | 1.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 483 | 0.960 |
Why?
|
| Cell Line, Tumor | 11 | 2024 | 1374 | 0.900 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 59 | 0.830 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 73 | 0.820 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 183 | 0.810 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 404 | 0.810 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 702 | 0.760 |
Why?
|
| Cell Death | 4 | 2025 | 268 | 0.740 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2020 | 19 | 0.730 |
Why?
|
| Biological Assay | 1 | 2021 | 54 | 0.720 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 56 | 0.710 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2020 | 17 | 0.690 |
Why?
|
| Optical Imaging | 1 | 2021 | 68 | 0.680 |
Why?
|
| Neoplasms | 5 | 2022 | 1244 | 0.660 |
Why?
|
| ErbB Receptors | 4 | 2020 | 113 | 0.620 |
Why?
|
| Stromal Cells | 1 | 2018 | 65 | 0.600 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1129 | 0.550 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 255 | 0.540 |
Why?
|
| Fibroblasts | 1 | 2018 | 370 | 0.540 |
Why?
|
| Systems Biology | 2 | 2015 | 28 | 0.520 |
Why?
|
| Interferon-beta | 1 | 2015 | 76 | 0.470 |
Why?
|
| Interferon-alpha | 1 | 2015 | 98 | 0.470 |
Why?
|
| Phosphorylation | 2 | 2016 | 859 | 0.460 |
Why?
|
| Protein Binding | 2 | 2016 | 1553 | 0.460 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2024 | 419 | 0.460 |
Why?
|
| Heme | 1 | 2014 | 27 | 0.450 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2024 | 530 | 0.440 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 201 | 0.430 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 98 | 0.430 |
Why?
|
| Drug Synergism | 3 | 2024 | 132 | 0.430 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 432 | 0.360 |
Why?
|
| Humans | 21 | 2025 | 59474 | 0.340 |
Why?
|
| Kinetics | 2 | 2021 | 733 | 0.310 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 749 | 0.300 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 80 | 0.290 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 60 | 0.290 |
Why?
|
| Models, Theoretical | 3 | 2019 | 258 | 0.280 |
Why?
|
| Transcription Factors | 3 | 2024 | 1457 | 0.270 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 72 | 0.250 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 439 | 0.250 |
Why?
|
| Calcineurin | 1 | 2024 | 42 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2024 | 186 | 0.220 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 73 | 0.220 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 117 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2020 | 942 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 185 | 0.210 |
Why?
|
| Ubiquitination | 2 | 2016 | 106 | 0.200 |
Why?
|
| Mitochondria | 2 | 2024 | 336 | 0.200 |
Why?
|
| Computer Simulation | 1 | 2025 | 458 | 0.200 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 44 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 299 | 0.190 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 143 | 0.190 |
Why?
|
| Hydrogels | 2 | 2021 | 106 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 277 | 0.180 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2019 | 53 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2021 | 174 | 0.180 |
Why?
|
| Drug Antagonism | 1 | 2020 | 9 | 0.180 |
Why?
|
| Intelligence | 1 | 2020 | 56 | 0.170 |
Why?
|
| Models, Neurological | 1 | 2020 | 81 | 0.170 |
Why?
|
| Beclin-1 | 1 | 2019 | 20 | 0.170 |
Why?
|
| Bioprinting | 1 | 2019 | 1 | 0.160 |
Why?
|
| Benchmarking | 1 | 2020 | 135 | 0.160 |
Why?
|
| Cell Line | 2 | 2021 | 2013 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2016 | 125 | 0.160 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 23 | 0.150 |
Why?
|
| Endosomes | 1 | 2019 | 169 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2018 | 93 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2019 | 211 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 796 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 80 | 0.150 |
Why?
|
| Tissue Engineering | 1 | 2019 | 133 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2018 | 103 | 0.140 |
Why?
|
| Allosteric Site | 1 | 2016 | 31 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 59 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 153 | 0.130 |
Why?
|
| Protein Domains | 1 | 2016 | 140 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2024 | 123 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2014 | 6 | 0.110 |
Why?
|
| Biotransformation | 1 | 2014 | 19 | 0.110 |
Why?
|
| Lignans | 1 | 2014 | 15 | 0.110 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 29 | 0.110 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 20 | 0.110 |
Why?
|
| Female | 5 | 2020 | 30895 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 51 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 74 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 59 | 0.110 |
Why?
|
| Drug Resistance, Multiple | 1 | 2014 | 34 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 307 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2016 | 492 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2014 | 90 | 0.110 |
Why?
|
| Proteomics | 1 | 2015 | 256 | 0.110 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 422 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2019 | 499 | 0.100 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2014 | 171 | 0.100 |
Why?
|
| Brain | 1 | 2020 | 1488 | 0.100 |
Why?
|
| Animals | 4 | 2024 | 19652 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2012 | 61 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 74 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 70 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 229 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2014 | 768 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 130 | 0.090 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2024 | 18 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 251 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2024 | 379 | 0.090 |
Why?
|
| Models, Biological | 2 | 2012 | 1141 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2014 | 1128 | 0.080 |
Why?
|
| Proteins | 1 | 2015 | 740 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1538 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 9 | 0.080 |
Why?
|
| Vacuoles | 1 | 2009 | 27 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 140 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 758 | 0.080 |
Why?
|
| Chromatin | 1 | 2013 | 594 | 0.080 |
Why?
|
| Pheromones | 1 | 2008 | 21 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2004 | 7 | 0.060 |
Why?
|
| Calcium Chloride | 1 | 2024 | 18 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 95 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 48 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 118 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1131 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 202 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 168 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2022 | 92 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 323 | 0.050 |
Why?
|
| Time Factors | 1 | 2008 | 3578 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 163 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 35 | 0.040 |
Why?
|
| Insulin | 1 | 2024 | 686 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 119 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 209 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 343 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 82 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2019 | 149 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2019 | 155 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 427 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 575 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 324 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 416 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 384 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 10273 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1046 | 0.030 |
Why?
|
| Quinazolines | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, Death Domain | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 34 | 0.030 |
Why?
|
| Liposomes | 1 | 2014 | 99 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 99 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 68 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 16 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1294 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 111 | 0.030 |
Why?
|
| Lysine | 1 | 2013 | 75 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 305 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 195 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 879 | 0.020 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 20 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 150 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 22 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 233 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 557 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 454 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 376 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 327 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 463 | 0.020 |
Why?
|
| Protein Transport | 1 | 2004 | 394 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2445 | 0.010 |
Why?
|